Copertina

Compartmentalisation in cAMP signalling: A phase separation perspective

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Milda Folkmanaite, Manuela Zaccolo
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Atrial natriuretic peptide counteracts aldosterone secretion by preventing acute angiotensin II‐induced cAMP signalling
di: Sanika Mohagaonkar, et al.
Pubblicazione: (2026)

Role of protein kinase A and A kinase anchoring proteins in buffering and compartmentation of cAMP signalling in human airway smooth muscle cells
di: Rinzhin T. Sherpa, et al.
Pubblicazione: (2024)

PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3‐L1 adipocytes
di: Johannes Krier, et al.
Pubblicazione: (2025)

Intracellular pathways of calcitonin gene‐related peptide‐induced relaxation of human coronary arteries: A key role for Gβγ subunit instead of cAMP
di: Tessa de Vries, et al.
Pubblicazione: (2024)

Regulation, effects and monitoring of compartmented cGMP signalling in cardiomyocytes—current status
di: Kjetil Wessel Andressen, et al.
Pubblicazione: (2025)

AMP‐activated protein kinase in the amygdala and hippocampus contributes to enhanced fear memory in diabetic mice
di: Aimi Yamagishi, et al.
Pubblicazione: (2024)

Genetic deficiency or pharmacological inhibition of cGAS–STING signalling suppresses kidney inflammation and fibrosis
di: Baihai Jiao, et al.
Pubblicazione: (2025)

The expression of contextual fear conditioning involves the dorsal hippocampus TRPV1 receptor interacting with the NMDA/NO/cGMP signalling pathway
di: Gabriela L. Bertacchini, et al.
Pubblicazione: (2024)

Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation
di: Alisha Niskala, et al.
Pubblicazione: (2024)

Immunotherapy in cancer: novel approaches and future perspectives
di: Barbara Stefanska, et al.
Pubblicazione: (2025)

The potential for biased signalling in the P2Y receptor family of GPCRs
di: Claudia M. Sisk, et al.
Pubblicazione: (2025)

A quad‐cistronic fluorescent biosensor system for real‐time detection of subcellular Ca2+ signals
di: Anna Lischnig, et al.
Pubblicazione: (2025)

Natural product pharmacology: the British Journal of Pharmacology perspective
di: Xin Wang, et al.
Pubblicazione: (2024)

Amylin analogues as a novel perspective in anti‐obesity therapy
di: Thomas A. Lutz
Pubblicazione: (2026)

Cannabigerol reverses mechanical allodynia through α 2A ‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy
di: Quinn W. Wade, et al.
Pubblicazione: (2025)

An agonist of the adenosine A2A receptor, CGS21680, promotes corneal epithelial wound healing via the YAP signalling pathway
di: Qiuqin Sun, et al.
Pubblicazione: (2024)

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology
di: Lucas Wittenkeller, et al.
Pubblicazione: (2025)

Fn14 signalling participates in pristane‐induced murine lupus through exacerbating oxidative stress
di: Zhu Yan, et al.
Pubblicazione: (2026)

Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling
di: Mingdian Tan, et al.
Pubblicazione: (2025)

Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
di: Marta Lopez‐Balastegui, et al.
Pubblicazione: (2024)

Diminished nuclear‐localized β‐adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy
di: Wenjing Xiang, et al.
Pubblicazione: (2024)

Synergistic RU486 and olaparib therapy enhances apoptosis in endometriosis by simultaneously targeting hormonal signalling and DNA repair
di: Yujie Peng, et al.
Pubblicazione: (2026)

Non‐canonical nitric oxide signalling and DNA methylation: Inflammation induced epigenetic alterations and potential drug targets
di: Christopher H. Switzer
Pubblicazione: (2024)

Macrocyclic diterpenoids from Stellera chamaejasme roots alleviate imiquimod‐induced psoriasiform inflammation via STAT1/S100A9 signalling pathway
di: Yi‐Wen Nie, et al.
Pubblicazione: (2025)

Cordycepin alleviates ischaemic brain injury by suppressing microglia‐induced neuroinflammation via regulating the Notch1 signalling pathway
di: Xing Li, et al.
Pubblicazione: (2026)

Commentary on: Activation of Nrf2 signalling pathway by tectoridin protects against ferroptosis in particulate matter‐induced lung injury
di: Wenfu Cao, et al.
Pubblicazione: (2024)

Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain
di: Siddhesh S. Sabnis, et al.
Pubblicazione: (2024)

Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles
di: Denise Pajonczyk, et al.
Pubblicazione: (2024)

Monovalent glycoconjugates of sulforaphane prevent inflammation induced by lipopolysaccharide in human dendritic cells by inhibiting NF‐ĸB signalling pathway
di: Camila Leiva‐Castro, et al.
Pubblicazione: (2025)

Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel
di: Chen Pan, et al.
Pubblicazione: (2024)

Tert‐butylhydroquinone promotes skin flap survival by inhibiting oxidative stress mediated by the Nrf2/HO‐1 signalling pathway
di: Kaitao Wang, et al.
Pubblicazione: (2024)

Educate to medicate: A clinical pharmacologist's perspective
di: Robert Likic, et al.
Pubblicazione: (2025)

Metformin aggravates pancreatitis by regulating the release of oxidised mitochondrial DNA via the frataxin (FXN)/ninjurin 1 (NINJ1) signalling pathway
di: Guang Xin, et al.
Pubblicazione: (2025)

Ginsenoside Rf protects against acetaminophen‐induced liver injury by targeting CCAR2 to activate the SIRT1‐FXR signalling pathway
di: Jingjing Fan, et al.
Pubblicazione: (2026)

Asthma and inflammation transcriptionally up‐regulate the aryl hydrocarbon receptor in airway smooth muscle via p38/JNK‐AP1 signalling
di: Mohammad Irshad Reza, et al.
Pubblicazione: (2025)

NPY Y 1 and Y 2 receptors in the regulation of mouse recognition and procedural memory: Interplay with cellular signalling, noradrenergic transmission and monoamine concentrations
di: Agnieszka Michalak, et al.
Pubblicazione: (2025)

5‐HT 2A receptor agonism by tert ‐leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence
di: Giorgia Corli, et al.
Pubblicazione: (2026)

Imperatorin ameliorates metabolic dysfunction‐associated fatty liver disease through modulating Suv39h1/Fabps/Cept1 signalling pathway
di: Yi Sun, et al.
Pubblicazione: (2025)

TREM2 activation reduces white matter injury via PI3K/Akt/GSK‐3β signalling after intracerebral haemorrhage
di: Yuan Zhang, et al.
Pubblicazione: (2025)

Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers
di: Irina Baltcheva, et al.
Pubblicazione: (2026)